Wouter Joustra MSc
General Partner
Leading the advancement of biologics for targeted immune regulation & restoration
Navigator Medicines is a clinical-stage biotech advancing bispecific antibodies anchored in OX40L inhibition. Its team is working to bring new hope to people living with complex inflammatory disorders and autoimmune diseases.
The company develops bispecific antibodies that simultaneously block OX40L and TNFα, targeting two key drivers of inflammation to deliver better, longer-lasting results for patients.
Human Health
US
Navigator Medicines, Inc.
2525 Smith Street
Scotch Plains, NJ 07076
Industry
Biotech
Status
Current
Location
US
Navigator’s growth journey has been driven by a shared vision of precision, perseverance, and purpose. With Forbion’s strategic support and sector expertise, we have been able to accelerate our science and scale our impact. They’ve been more than investors; they have been true partners - both from a scientific and business perspective.Tausif ‘Tosh’ Butt
CEO of Navigator
